{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:19:57Z","timestamp":1776259197792,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1245\/s10434-025-18675-x","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T19:34:09Z","timestamp":1762803249000},"page":"4365-4375","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Analysis of PIPAC Nozzle Designs: Ex Vivo Evaluation of Aerosol Distribution, Penetration, and Tissue Concentration"],"prefix":"10.1245","volume":"33","author":[{"given":"Elias","family":"Karam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Kockelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Romdhane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Barbey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roselyne","family":"Viel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"S\u00e9billot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Roger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Michot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urs","family":"Giger-Pabst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Ouaissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"21","key":"18675_CR1","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.3390\/jcm10214882","volume":"10","author":"A Rijken","year":"2021","unstructured":"Rijken A, Lurvink RJ, Luyer MDP, et al. The burden of peritoneal metastases from gastric cancer: a systematic review on the incidence, risk factors and survival. JCM. 2021;10(21):4882. https:\/\/doi.org\/10.3390\/jcm10214882.","journal-title":"JCM."},{"key":"18675_CR2","doi-asserted-by":"publisher","first-page":"1104694","DOI":"10.3389\/fimmu.2023.1104694","volume":"14","author":"T Miyamoto","year":"2023","unstructured":"Miyamoto T, Murphy B, Zhang N. Intraperitoneal metastasis of ovarian cancer: new insights on resident macrophages in the peritoneal cavity. Front Immunol. 2023;14:1104694. https:\/\/doi.org\/10.3389\/fimmu.2023.1104694.","journal-title":"Front Immunol."},{"key":"18675_CR3","unstructured":"Anwar A, Kasi A. Peritoneal Cancer. [Updated 2024 Apr 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. Available from: https:\/\/www.ncbi.nlm.nih.gov\/sites\/books\/NBK562138\/?utm_source=chatgpt.com."},{"issue":"4","key":"18675_CR4","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1245\/s10434-022-12969-0","volume":"30","author":"MV Dietz","year":"2023","unstructured":"Dietz MV, Ziekman MJ, Van Kooten JP, et al. Treatment and survival outcomes for patients with colorectal peritoneal metastases deemed ineligible for cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC): results of a retrospective study. Ann Surg Oncol. 2023;30(4):2048\u201356. https:\/\/doi.org\/10.1245\/s10434-022-12969-0.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"18675_CR5","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1245\/s10434-024-15131-0","volume":"31","author":"RGFM Van Der Ven","year":"2024","unstructured":"Van Der Ven RGFM, Van Den Heuvel TBM, Rovers KPB, et al. Towards equal access to cytoreductive surgery with hyperthermic intraperitoneal chemotherapy and survival in patients with isolated colorectal peritoneal metastases: a nationwide population-based study. Ann Surg Oncol. 2024;31(6):3758\u201368. https:\/\/doi.org\/10.1245\/s10434-024-15131-0.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"18675_CR6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1245\/s10434-018-6860-4","volume":"26","author":"Y Feferman","year":"2019","unstructured":"Feferman Y, Solomon D, Bhagwandin S, et al. Sites of recurrence after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis from colorectal and appendiceal adenocarcinoma: a tertiary center experience. Ann Surg Oncol. 2019;26(2):482\u20139. https:\/\/doi.org\/10.1245\/s10434-018-6860-4.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"18675_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3390\/cancers16030631","volume":"16","author":"MF Nielsen","year":"2024","unstructured":"Nielsen MF, Ravn S, S\u00f8rensen MM, Funder JA, Iversen LH. Recurrence and survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for synchronous and metachronous peritoneal metastases of colorectal origin. Cancers. 2024;16(3):631. https:\/\/doi.org\/10.3390\/cancers16030631.","journal-title":"Cancers."},{"issue":"6","key":"18675_CR8","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1007\/s00268-015-2986-8","volume":"39","author":"JFS Wong","year":"2015","unstructured":"Wong JFS, Tan GHC, Wang W, Soo KC, Teo MCC. Repeat cytoreductive surgery and HIPEC for peritoneal surface malignancy and peritoneal carcinomatosis. World J Surg. 2015;39(6):1578\u201383. https:\/\/doi.org\/10.1007\/s00268-015-2986-8.","journal-title":"World J Surg."},{"issue":"5","key":"18675_CR9","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/S1470-2045(18)30132-3","volume":"19","author":"A Cats","year":"2018","unstructured":"Cats A, Jansen EPM, Van Grieken NCT, et al. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. Lancet Oncol. 2018;19(5):616\u201328. https:\/\/doi.org\/10.1016\/S1470-2045(18)30132-3.","journal-title":"Lancet Oncol."},{"issue":"7","key":"18675_CR10","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/jnci\/89.7.480","volume":"89","author":"RL Dedrick","year":"1997","unstructured":"Dedrick RL, Flessner MF. Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. JNCI J Natl Cancer Inst. 1997;89(7):480\u20137. https:\/\/doi.org\/10.1093\/jnci\/89.7.480.","journal-title":"JNCI J Natl Cancer Inst."},{"issue":"10","key":"18675_CR11","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrc1456","volume":"4","author":"CH Heldin","year":"2004","unstructured":"Heldin CH, Rubin K, Pietras K, \u00d6stman A. High interstitial fluid pressure\u2014an obstacle in cancer therapy. Nat Rev Cancer. 2004;4(10):806\u201313. https:\/\/doi.org\/10.1038\/nrc1456.","journal-title":"Nat Rev Cancer."},{"key":"18675_CR12","doi-asserted-by":"publisher","first-page":"103109","DOI":"10.1016\/j.eclinm.2025.103109","volume":"81","author":"NAD Guchelaar","year":"2025","unstructured":"Guchelaar NAD, De Neijs MJ, Noordman BJ, et al. The prognostic value of peritoneal metastases in patients with gastric cancer: a nationwide population-based study. eClin Med. 2025;81:103109. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103109.","journal-title":"eClin Med."},{"issue":"10294","key":"18675_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398(10294):27\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(21)00797-2.","journal-title":"Lancet."},{"issue":"1","key":"18675_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006;354(1):34\u201343. https:\/\/doi.org\/10.1056\/NEJMoa052985.","journal-title":"N Engl J Med."},{"issue":"8","key":"18675_CR15","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2165\/00003495-200161080-00003","volume":"61","author":"M Markman","year":"2001","unstructured":"Markman M. Intraperitoneal drug delivery of antineoplastics. Drugs. 2001;61(8):1057\u201365. https:\/\/doi.org\/10.2165\/00003495-200161080-00003.","journal-title":"Drugs."},{"key":"18675_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005340.pub4","author":"K Jaaback","year":"2016","unstructured":"Jaaback K, Johnson N, Lawrie TA. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. Cochrane Database Syst Rev. 2016. https:\/\/doi.org\/10.1002\/14651858.CD005340.pub4.","journal-title":"Cochrane Database Syst Rev."},{"issue":"6","key":"18675_CR17","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1200\/JCO.2005.05.2456","volume":"24","author":"M Markman","year":"2006","unstructured":"Markman M, Walker JL. Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment. JCO. 2006;24(6):988\u201394. https:\/\/doi.org\/10.1200\/JCO.2005.05.2456.","journal-title":"JCO."},{"issue":"3","key":"18675_CR18","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00464-011-1964-y","volume":"26","author":"W Solass","year":"2012","unstructured":"Solass W, Herbette A, Schwarz T, et al. Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept. Surg Endosc. 2012;26(3):847\u201352. https:\/\/doi.org\/10.1007\/s00464-011-1964-y.","journal-title":"Surg Endosc."},{"issue":"1","key":"18675_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/cancers12010034","volume":"12","author":"G Nadiradze","year":"2019","unstructured":"Nadiradze G, Horvath P, Sautkin Y, et al. Overcoming drug resistance by taking advantage of physical principles: pressurized intraperitoneal aerosol chemotherapy (PIPAC). Cancers. 2019;12(1):34. https:\/\/doi.org\/10.3390\/cancers12010034.","journal-title":"Cancers."},{"issue":"7","key":"18675_CR20","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1158\/1078-0432.CCR-20-2152","volume":"27","author":"G Kim","year":"2021","unstructured":"Kim G, Tan HL, Sundar R, et al. PIPAC-OX: a phase I study of oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy in patients with peritoneal metastases. Clin Cancer Res. 2021;27(7):1875\u201381. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-2152.","journal-title":"Clin Cancer Res."},{"issue":"5","key":"18675_CR21","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3390\/cancers13051060","volume":"13","author":"M Robella","year":"2021","unstructured":"Robella M, De Simone M, Berchialla P, et al. A phase I dose escalation study of oxaliplatin, cisplatin and doxorubicin applied as PIPAC in patients with peritoneal carcinomatosis. Cancers. 2021;13(5):1060. https:\/\/doi.org\/10.3390\/cancers13051060.","journal-title":"Cancers."},{"issue":"4","key":"18675_CR22","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1245\/s10434-022-12698-4","volume":"30","author":"G Ramos Arias","year":"2023","unstructured":"Ramos Arias G, Sindayigaya R, Ouaissi M, et al. Safety and feasibility of high-pressure\/high-dose pressurized intraperitoneal aerosol chemotherapy (HP\/HD-PIPAC) for primary and metastatic peritoneal surface malignancies. Ann Surg Oncol. 2023;30(4):2497\u2013505. https:\/\/doi.org\/10.1245\/s10434-022-12698-4.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"18675_CR23","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","volume":"20","author":"M Alyami","year":"2019","unstructured":"Alyami M, H\u00fcbner M, Grass F, et al. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. Lancet Oncol. 2019;20(7):e368\u201377. https:\/\/doi.org\/10.1016\/S1470-2045(19)30318-3.","journal-title":"Lancet Oncol."},{"issue":"4","key":"18675_CR24","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s00464-016-5174-5","volume":"31","author":"D G\u00f6hler","year":"2017","unstructured":"G\u00f6hler D, Khosrawipour V, Khosrawipour T, et al. Technical description of the microinjection pump (MIP\u00ae) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC). Surg Endosc. 2017;31(4):1778\u201384. https:\/\/doi.org\/10.1007\/s00464-016-5174-5.","journal-title":"Surg Endosc."},{"issue":"1","key":"18675_CR25","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00464-017-5652-4","volume":"32","author":"A Bellendorf","year":"2018","unstructured":"Bellendorf A, Khosrawipour V, Khosrawipour T, et al. Scintigraphic peritoneography reveals a non-uniform 99mTc-Pertechnetat aerosol distribution pattern for pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in a swine model. Surg Endosc. 2018;32(1):166\u201374. https:\/\/doi.org\/10.1007\/s00464-017-5652-4.","journal-title":"Surg Endosc."},{"issue":"5","key":"18675_CR26","doi-asserted-by":"publisher","first-page":"e0300241","DOI":"10.1371\/journal.pone.0300241","volume":"19","author":"D G\u00f6hler","year":"2024","unstructured":"G\u00f6hler D, Oelschl\u00e4gel K, Ouaissi M, Giger-Pabst U. Performance of different nebulizers in clinical use for pressurized intraperitoneal aerosol chemotherapy (PIPAC). PLoS ONE. 2024;19(5):e0300241. https:\/\/doi.org\/10.1371\/journal.pone.0300241.","journal-title":"PLoS ONE."},{"issue":"8","key":"18675_CR27","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3390\/cancers16081559","volume":"16","author":"D Hoskovec","year":"2024","unstructured":"Hoskovec D, Kr\u0161ka Z, Vo\u010dka M, Argal\u00e1csov\u00e1 S, Dytrych P. Pressurised intraperitoneal aerosolised chemotherapy\u2014results from the first hundred consecutive procedures. Cancers (Basel). 2024;16(8):1559. https:\/\/doi.org\/10.3390\/cancers16081559.","journal-title":"Cancers (Basel)."},{"key":"18675_CR28","doi-asserted-by":"publisher","unstructured":"Kockelmann F, G\u00f6hler D, Barbey S, et al. Chemical\/technical risk analysis of a new multi-directional nebulizer (MDN) and its clinical implementation for the safe administration of pressurized intraperitoneal aerosol chemotherapy (MDN-PIPAC). medRxiv. Preprint posted online December 15, 2023:2023.12.01.23297348. https:\/\/doi.org\/10.1101\/2023.12.01.23297348","DOI":"10.1101\/2023.12.01.23297348"},{"issue":"4","key":"18675_CR29","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1245\/s10434-015-4954-9","volume":"23","author":"V Khosrawipour","year":"2016","unstructured":"Khosrawipour V, Khosrawipour T, Diaz-Carballo D, F\u00f6rster E, Zieren J, Giger-Pabst U. Exploring the spatial drug distribution pattern of pressurized intraperitoneal aerosol chemotherapy (PIPAC). Ann Surg Oncol. 2016;23(4):1220\u20134. https:\/\/doi.org\/10.1245\/s10434-015-4954-9.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"18675_CR30","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1245\/s10434-013-3039-x","volume":"20","author":"W Sola\u00df","year":"2013","unstructured":"Sola\u00df W, Giger-Pabst U, Zieren J, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects. Ann Surg Oncol. 2013;20(11):3504\u201311. https:\/\/doi.org\/10.1245\/s10434-013-3039-x.","journal-title":"Ann Surg Oncol."},{"issue":"13","key":"18675_CR31","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1245\/s10434-019-07695-z","volume":"26","author":"U Giger-Pabst","year":"2019","unstructured":"Giger-Pabst U, Bucur P, Roger S, et al. Comparison of tissue and blood concentrations of oxaliplatin administrated by different modalities of intraperitoneal chemotherapy. Ann Surg Oncol. 2019;26(13):4445\u201351. https:\/\/doi.org\/10.1245\/s10434-019-07695-z.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"18675_CR32","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s12885-019-5658-5","volume":"19","author":"L Van De Sande","year":"2019","unstructured":"Van De Sande L, Willaert W, Cosyns S, et al. Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC). BMC Cancer. 2019;19(1):424. https:\/\/doi.org\/10.1186\/s12885-019-5658-5.","journal-title":"BMC Cancer."},{"issue":"9","key":"18675_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11095-019-2646-z","volume":"36","author":"M Shariati","year":"2019","unstructured":"Shariati M, Zhang H, Van De Sande L, et al. High pressure nebulization (PIPAC) versus injection for the intraperitoneal administration of mRNA complexes. Pharm Res. 2019;36(9):126. https:\/\/doi.org\/10.1007\/s11095-019-2646-z.","journal-title":"Pharm Res."},{"key":"18675_CR34","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-17251-7","author":"SM Bardet","year":"2025","unstructured":"Bardet SM, Perrin ML, David V, et al. Feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a rabbit model of peritoneal metastases: PIPALIM project. Ann Surg Oncol. 2025. https:\/\/doi.org\/10.1245\/s10434-025-17251-7.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"18675_CR35","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.1007\/s00464-024-11172-4","volume":"38","author":"Y Sautkin","year":"2024","unstructured":"Sautkin Y, Weinreich J, Reymond MA. A multi-nozzle nebuliser does not improve tissue drug delivery during PIPAC. Surg Endosc. 2024;38(10):5832\u201341. https:\/\/doi.org\/10.1007\/s00464-024-11172-4.","journal-title":"Surg Endosc."},{"key":"18675_CR36","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.actbio.2023.08.027","volume":"170","author":"H Braet","year":"2023","unstructured":"Braet H, Andretto V, Mari\u00ebn R, et al. The effect of electrostatic high pressure nebulization on the stability, activity and ex vivo distribution of ionic self-assembled nanomedicines. Acta Biomater. 2023;170:318\u201329. https:\/\/doi.org\/10.1016\/j.actbio.2023.08.027.","journal-title":"Acta Biomater."},{"issue":"3","key":"18675_CR37","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.21037\/gs-2019-ursoc-11","volume":"10","author":"J Mun","year":"2021","unstructured":"Mun J, Park SJ, Kim HS. Rotational intraperitoneal pressurized aerosol chemotherapy in a porcine model. Gland Surg. 2021;10(3):1271\u20135. https:\/\/doi.org\/10.21037\/gs-2019-ursoc-11.","journal-title":"Gland Surg."},{"issue":"1","key":"18675_CR38","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1080\/10717544.2021.1937382","volume":"28","author":"SJ Park","year":"2021","unstructured":"Park SJ, Lee EJ, Lee HS, et al. Development of rotational intraperitoneal pressurized aerosol chemotherapy to enhance drug delivery into the peritoneum. Drug Deliv. 2021;28(1):1179\u201387. https:\/\/doi.org\/10.1080\/10717544.2021.1937382.","journal-title":"Drug Deliv."},{"key":"18675_CR39","volume-title":"Aerosol technology: properties, behavior, and measurement of airborne particles","author":"WC Hinds","year":"1999","unstructured":"Hinds WC. Aerosol technology: properties, behavior, and measurement of airborne particles. 2nd edn. Hoboken: Wiley-Interscience; 1999.","edition":"2"},{"issue":"4","key":"18675_CR40","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1007\/s00464-020-07546-z","volume":"35","author":"L Toussaint","year":"2021","unstructured":"Toussaint L, Sautkin Y, Illing B, et al. Comparison between microcatheter and nebulizer for generating pressurized intraperitoneal aerosol chemotherapy (PIPAC). Surg Endosc. 2021;35(4):1636\u201343. https:\/\/doi.org\/10.1007\/s00464-020-07546-z.","journal-title":"Surg Endosc."},{"issue":"3","key":"18675_CR41","doi-asserted-by":"publisher","first-page":"20190017","DOI":"10.1515\/pp-2019-0017","volume":"4","author":"I Sautkin","year":"2019","unstructured":"Sautkin I, Solass W, Weinreich FJ, et al. A real-time ex vivo model (eIBUB) for optimizing intraperitoneal drug delivery as an alternative to living animal models. Pleura Peritoneum. 2019;4(3):20190017. https:\/\/doi.org\/10.1515\/pp-2019-0017.","journal-title":"Pleura Peritoneum."},{"issue":"9","key":"18675_CR42","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.21873\/anticanres.11008","volume":"36","author":"V Khosrawipour","year":"2016","unstructured":"Khosrawipour V, Khosrawipour T, Falkenstein TA, et al. Evaluating the effect of Micropump\u00a9 position, internal pressure and doxorubicin dosage on efficacy of pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in an ex vivo model. AR. 2016;36(9):4595\u2013600. https:\/\/doi.org\/10.21873\/anticanres.11008.","journal-title":"AR."},{"key":"18675_CR43","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.3762\/bjnano.8.272","volume":"8","author":"D G\u00f6hler","year":"2017","unstructured":"G\u00f6hler D, Gro\u00dfe S, Bellendorf A, et al. Hyperthermic intracavitary nanoaerosol therapy (HINAT) as an improved approach for pressurised intraperitoneal aerosol chemotherapy (PIPAC): technical description, experimental validation and first proof of concept. Beilstein J Nanotechnol. 2017;8:2729\u201340. https:\/\/doi.org\/10.3762\/bjnano.8.272.","journal-title":"Beilstein J Nanotechnol."},{"issue":"2","key":"18675_CR44","doi-asserted-by":"publisher","first-page":"2384586","DOI":"10.1080\/0886022X.2024.2384586","volume":"46","author":"YW Chen","year":"2024","unstructured":"Chen YW, Liao CT, Wu MY, et al. Pressure induces peritoneal fibrosis and inflammation through CD44 signaling. Renal Fail. 2024;46(2):2384586. https:\/\/doi.org\/10.1080\/0886022X.2024.2384586.","journal-title":"Renal Fail"},{"issue":"1","key":"18675_CR45","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12967-022-03533-1","volume":"20","author":"EJ Lee","year":"2022","unstructured":"Lee EJ, Park SJ, Seol A, et al. Establishment of a piglet model for peritoneal metastasis of ovarian cancer. J Transl Med. 2022;20(1):329. https:\/\/doi.org\/10.1186\/s12967-022-03533-1.","journal-title":"J Transl Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18675-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18675-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18675-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:26:06Z","timestamp":1776255966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18675-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["18675"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18675-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have not disclosed any conflicts of interest or financial ties. It is further noted that none of the authors of this study have any relationships with the manufacturers or distributors of PIPAC nozzles. The data generated in this study are available upon reasonable request to the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}